(Allergan plc)

	AGN latest price $242.3526 (1.12%) ($239.8046 - $244.4856) on Tue. Aug. 9, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.74% (three month average)
RSI	57
Latest Price	$242.3526(1.12%)
Stocks Behave Similarly	Similar Stock List
Weekly Trend	AGN advances 0.6% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(52%)    XLV(51%)    XBI(46%)    ARKG(43%)    SPY(42%)
Factors Impacting AGN price	AGN will decline at least -0.87% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-12%)    IPO(-7%)    SHY(-3%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.87% (StdDev 1.74%)
Hourly BBV	0 ()
Intraday Trend	0.8%

5 Day Moving Average	$243.07(-0.3%)
10 Day Moving Average	$244.4(-0.84%)
20 Day Moving Average	$240.98(0.57%)
To recent high	-3.5%
To recent low	17.5%
Market Cap	$79.904b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed